Jupiter Life Line Hospitals Approves Q Results, Announces CFO Appointment and Subsidiary Acquisition
Jupiter Life Line Hospitals Limited announced key operational updates following its Board Meeting held on July 31, 2026. The board approved the unaudited financial results for both standalone and consolidated entities for the quarter ended June 30, 2026. Furthermore, the company reported that its subsidiary, Jupiter Hospital Pharmacy Private Limited (JHPPL), acquired a stake in Sulcus Private Limited.The Board meeting also saw the approval of Mr. Harshad Purani as the Chief Financial Officer and Key Managerial Personnel of the Company, effective July 31, 2026.
Q1 Results Highlighted
The unaudited standalone financial results for Jupiter Life Line Hospitals Limited showed a total income of ₹3,391.28 million for the quarter ended June 30, 2026. Revenue from operations stood at ₹3,284.85 million. The Company reported a net profit for the period of ₹371.89 million.The results were subjected to limited review by the joint statutory auditors, who issued an unmodified report.
A snapshot of the standalone financial performance is provided below:
| Particulars | Quarter Ended June 30, 2026 (₹ Million) | March 31, 2026 (₹ Million) | June 30, 2025 (₹ Million) | March 31, 2025 (₹ Million) |
|---|---|---|---|---|
| Revenue from operations | 3,284.85 | 3,124.21 | 2,119.87 | 77,916.24 |
| Total Income | 3,391.28 | 3,213.69 | 2,904.23 | 1,398.75 |
| Total Expenses | 2,490.15 | 2,569.80 | 2,300.73 | 9,789.50 |
| Profit before tax | 501.13 | 643.89 | 507.50 | 2,609.25 |
| Net Profit for the period | 371.89 | 492.01 | 432.94 | 1,913.80 |
Consolidated financial results reflected a total income of ₹4,215.69 million for the quarter ended June 30, 2026. Revenue from operations was reported at ₹4,109.83 million, and the Net Profit for the period stood at ₹375.12 million.
Key consolidated figures are presented in the table below:
| Particulars | Quarter Ended June 30, 2026 (₹ Million) | March 31, 2026 (₹ Million) | June 30, 2025 (₹ Million) | March 31, 2025 (₹ Million) |
|---|---|---|---|---|
| Revenue from operations | 4,109.83 | 3,878.38 | 3,529.53 | 14,997.47 |
| Total Income | 4,215.69 | 3,969.87 | 3,651.10 | 15,421.55 |
| Total Expenses | 3,710.16 | 3,309.40 | 3,040.22 | 12,764.32 |
| Net Profit for the period | 375.12 | 505.69 | 439.45 | 1,945.89 |
Strategic Acquisition of Sulcus Private Limited
The Board noted that Jupiter Hospital Pharmacy Private Limited (JHPPL), a subsidiary of the Company, acquired 100% of the equity share capital of Sulcus Private Limited for a consideration of ₹3.78 crore. With this acquisition, Sulcus has become a wholly owned subsidiary of JHPPL and a step down subsidiary of Jupiter Life Line Hospitals Limited.The acquisition pertains to Sulcus Private Limited, which is involved in setting up an IV fluids, infusions and pharmaceutical manufacturing facility near Ujjain, Madhya Pradesh, and operates in the pharmaceuticals industry. The rationale for acquiring Sulcus was stated as reducing costs and improving margins within JHPPL.
Officer Appointment Details
Mr. Harshad Purani has been appointed as the Chief Financial Officer and Key Managerial Personnel of Jupiter Life Line Hospitals Limited with effect from July 31, 2026. Mr. Purani is noted to be the President - Administration and Head of Corporate Social Responsibility, and he has been associated with the Company since September 9, 2007.JLHL Stock Price Movement
Shares of Jupiter Life Line Hospitals Limited slipped by 0.72% in post-market trading today, settling at ₹331.50 after shedding ₹2.40 from previous close. The stock traded a volume of 167,868 shares, closing well below the day's high of ₹334.50.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: